Compumedics Limited (CMP) Stock Statistics & Valuation Metrics

Compumedics Limited has a market cap or net worth of AU$54.78M. The enterprise value is ―.

Compumedics Limited has 192,217,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Compumedics Limited’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 0.71%.

The current PE Ratio of Compumedics Limited is -178.21. Compumedics Limited’s PEG ratio is 0.07.

In the last 12 months, Compumedics Limited had revenue of 49.72M and earned -338.00K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -1.30M and capital expenditures -273.00K, giving a free cash flow of -1.57M billion.

Compumedics Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Compumedics Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.

Compumedics Limited as a current ratio of 1.23, with Debt / Equity ratio of 58.70%

In the past 12 months, Compumedics Limited has paid 818.00K in taxes.

Compumedics Limited EV to EBITDA ratio is 24.00, with an EV/FCF ratio of -67.87.

Compumedics Limited has AU$3.96M in cash and marketable securities with AU$12.56M in debt, giving a net cash position of AU$8.59M billion.

Gross margin is 51.51%, with operating margin of -0.54%, and net profit margin of -0.68%.

The average price target for Compumedics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―